These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 10929624)

  • 1. [Epidemiology and pathophysiology of Barrett esophagus].
    Freys SM; Fuchs KH; Heimbucher J; Fein M; Thiede A
    Zentralbl Chir; 2000; 125(5):406-13. PubMed ID: 10929624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
    Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM
    Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of Barrett's esophagus].
    Mabrut JY; Baulieux J
    J Chir (Paris); 1999 Dec; 136(6):301-8. PubMed ID: 10675819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colonization with cagA-positive Helicobacter pylori strains in intestinal metaplasia of the esophagus and the esophagogastric junction.
    Ackermark P; Kuipers EJ; Wolf C; Breumelhof R; Seldenrijk CA; Timmer R; Segeren KC; Kusters JG; Smout AJ
    Am J Gastroenterol; 2003 Aug; 98(8):1719-24. PubMed ID: 12907324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GORD and Barrett's oesophagus: does oesophageal motility matter?
    Rodríguez-Téllez M
    Rev Esp Enferm Dig; 2002 Apr; 94(4):180-7. PubMed ID: 12185929
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathophysiology of Barrett's esophagus.
    Chandrasoma P
    Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):270-8. PubMed ID: 9263345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of intestinal metaplasia in patients with and without peptic strictures.
    Kim SL; Wo JM; Hunter JG; Davis LP; Waring JP
    Am J Gastroenterol; 1998 Jan; 93(1):53-5. PubMed ID: 9448174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Barrett's metaplasia].
    Mach T; Cibor D
    Folia Med Cracov; 1999; 40(3-4):5-16. PubMed ID: 10909470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Barrett's esophagus. Prevalence, risk of adenocarcinoma, role of endoscopic surveillance].
    Zaninotto G; Costantini M; Molena D; Rizzetto C; Ekser B; Ancona E
    Minerva Chir; 2002 Dec; 57(6):819-36. PubMed ID: 12592224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical outline of Barrett's esophagus].
    Kuwano H; Sohda M; Kato H; Miyazaki T; Kimura H
    Nihon Rinsho; 2005 Aug; 63(8):1372-8. PubMed ID: 16101224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carcinogenesis of Barrett's esophagus].
    Endo T; Sugawara N; Shinomura Y
    Nihon Rinsho; 2005 Aug; 63(8):1357-61. PubMed ID: 16101221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
    Kim R; Weissfeld JL; Reynolds JC; Kuller LH
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus.
    Vaezi MF; Falk GW; Peek RM; Vicari JJ; Goldblum JR; Perez-Perez GI; Rice TW; Blaser MJ; Richter JE
    Am J Gastroenterol; 2000 Sep; 95(9):2206-11. PubMed ID: 11007219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia.
    Csendes A; Smok G; Quiroz J; Burdiles P; Rojas J; Castro C; Henríquez A
    Am J Gastroenterol; 2002 Mar; 97(3):554-60. PubMed ID: 11922546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Helicobacter pylori in Barrett esophagus].
    Kogan Z; Corti R; Cabane A; Fiorini A; Monastra Varrica L; Fernández Marty P; Vasen W
    Acta Gastroenterol Latinoam; 1992; 22(4):215-9. PubMed ID: 1340675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association between symptomatic gastroesophageal reflux and Barrett's esophagus].
    Trujillo-Benavides OE; Baltazar-Montúfar P; Angeles-Garay U; Ramírez-Mendoza P; Navarro-García AM; Paredes-Cruz E; Méndez del Monte R; Guerrero-Hernández M
    Rev Gastroenterol Mex; 2005; 70(1):14-9. PubMed ID: 16170957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.